References
- Al-Shobaili HA, Al Robaee AA, Alzolibani AA, Rasheed Z. (2013). Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: Correlation with disease activity index. Immunol Invest, 42, 191–203
- Ávalos-Martínez CE, Rodríguez-Alba JC, Berrón-Ruiz L, et al. (2013). Measurement of suppressor activity of T CD4CD25 T reg cells using bromodeoxyuridine incorporation assay. Immunol Invest, 42, 369–81
- Ban JY, Kim MK, Park SW, Kwon KH. (2012). Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma. Immunol Invest, 41, 888–905
- Cohen PA, Ko JS, Storkus WJ, et al. (2012). Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape. Immunol Invest, 41, 680–710
- Cordeau M, Herblot S, Charrier E, et al. (2012). Defects in CD54 and CD86 up-regulation by plasmacytoid dendritic cells during pregnancy. Immunol Invest, 41, 497–506
- Cruz-Robles D, Chavez-Gonzalez JP, Cavazos-Quero MM, et al. (2009). Association between IL-1B and IL-1RN gene polymorphisms and Chagas' disease development susceptibility. Immunol Invest, 38, 231–9
- D’Amelio P. (2013). The immune system and postmenopausal osteoporosis. Immun Invest, 42, 544–54
- Durrant DM, Metzger DW. (2010). Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest, 39, 526–4
- Dziak R. (2013). The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells. Immun Invest, 42, 510–18
- Erfani N, Khademi B, Haghshenas MR, et al. (2013). Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma. Immunol Invest, 42, 81–90
- Funaoka H, Dohi Y, Ohgushi H, et al. (2010). Development of a high-specificity enzyme-linked immunosorbent assay (ELISA) system for the quantification and validation of intact rat osteocalcin. Immunol Invest, 39, 54–73
- Gomes DAS, Pires JR, Zuza EP, et al. (2009). Myeloperoxidase as inflammatory marker of periodontal disease: Experimental study in rats. Immunol Invest, 38, 117–22
- Haile LA, Greten TF, Korangy F. (2012). Immune suppression: The hallmark of myeloid derived suppressor cells. Immunol Invest, 41, 581–94
- Harden JL, Egilmez NK. (2012). Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest, 41, 738–64
- Horwood NJ. (2013). Immune cells and bone: Coupling goes both ways. Immunol Invest, 42, 532–43
- Jha HC, Srivastava P, Prasad J, Mittal A. (2011). Chlamydia pneumoniae heat shock protein 60 enhances expression of ERK, TLR-4 and IL-8 in atheromatous plaques of coronary artery disease patients. Immunol Invest, 40, 206–22
- Kadkhodazadeh M, Baghani Z, Ebadian AR, et al. (2013). IL-17 gene polymorphism is associated with chronic periodontitis and peri-implantitis in Iranian patients: A cross-sectional study. Immunol Invest, 42, 156–63
- Kohanbash G, Okada H. (2012). Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development. Immunol Invest, 41, 658–79
- Jackson SR, Berrien-Elliott MM, Meyer JM, et al. (2013). CD8+ T cell exhaustion during persistent viral infection is regulated independently of the virus-specific T cell receptor. Immunol Invest, 42, 204–20
- Latella MC, de Gaetano M, Di Castelnuovo A, et al. (2009). Interleukin 1 gene cluster, myocardial infarction at young age and inflammatory response of human mononuclear cells. Immunol Invest, 38, 203–19
- Lee J, Lim KT. (2013). Protection against cyclophosphamide-induced myelosuppression by ZPDC glycoprotein (24 kDa). Immunol Invest, 42, 61–80
- Liu M, Clemons KV, Johansen ME, et al. (2012). Saccharomyces as a vaccine against systemic candidiasis. Immunol Invest, 41, 847–55
- Manjili MH. (2012). Phenotypic plasticity of MDSC in cancers. Immunol Invest, 41, 711–21
- Monu NR, Frey AB. (2012). Myeloid-derived suppressor cells and anti-tumor T cells: A complex relationship. Immunol Invest, 41, 595–613
- Myneni SR, Settem RP, Sharma A. (2013). Bacteria take control of Tolls and T cells to destruct jaw-bone. Immunol Invest, 42, 519–31
- Negrini Tde C, Ferreira LS, Alegranci P, et al. (2013). Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Immunol Invest, 42, 36–48
- Noack B, Gorgens H, Lorenz K, et al. (2009). TLR4 and IL-18 gene variants in chronic periodontitis: Impact on disease susceptibility and severity. Immunol Invest, 38, 297–310
- Obermajer N, Wong JL, Edwards RP, et al. (2012). PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells. Immunol Invest, 41, 635–57
- Park S, Kang S, Min KH, et al. (2013). Age-associated changes in microRNA expression in bone marrow derived dendritic cells. Immunol Invest, 42, 179–90
- Rafferty BJ, Li G, McGee DW. (2010). Activation of the alpha3 integrin affects TRAF6 function in the IL-1 signaling pathway of CACO-2 epithelial cells. Immunol Invest, 39, 1–15
- Salah H, Atfy M, Fathy A, et al. (2010). The clinical significance of OPG/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients. Immunol Invest, 39, 820–32
- Solito S, Pinton L, Damuzzo V, Mandruzzato S. (2012). Highlights on molecular mechanisms of MDSC-mediated immune suppression: Paving the way for new working hypotheses. Immunol Invest, 41, 722–37
- Souza PPC, Lerner UH. (2013). The role of cytokines in inflammatory bone loss. Immun Inv, 42, 555–622
- Tunceroglu H, Shah A, Porhomayon J, Nader ND. (2013). Biomarkers of lung injury in critical care medicine: Past, present, and future. Immunol Invest, 42, 247–61
- Velaga S, Ukena SN, Hopting M, et al. (2013). Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation. Immunol Invest, 42, 18–35
- Zoghi S, Amirghofran Z, Nikseresht A, et al. (2011). Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters. Immunol Invest, 40, 581–96